Compare EQS & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | EQS | ALUR |
|---|---|---|
| Founded | 1991 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 18.9M |
| IPO Year | N/A | N/A |
| Metric | EQS | ALUR |
|---|---|---|
| Price | $1.31 | $1.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 24.9K | ★ 77.4K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,377,000.00 | ★ $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.11 | N/A |
| 52 Week Low | $0.74 | $1.02 |
| 52 Week High | $2.49 | $16.81 |
| Indicator | EQS | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 25.99 | 59.17 |
| Support Level | $1.27 | $1.18 |
| Resistance Level | $1.44 | $1.91 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 9.32 | 79.37 |
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.